Welcome to the website for the laboratory of Dr. Levi A. Garraway at the Dana-Farber Cancer Institute and the Broad Institute. Our laboratory is engaged in systematic genomic and functional studies to elucidate cellular pathways perturbed by recurrent genomic alterations in cancer, and to identify avenues for therapeutic intervention. Our major areas of emphasis are melanoma and prostate cancer. The range of projects ongoing in our laboratory are related to the study of mechanisms of carcinogenesis, mechanisms of resistance to targeted therapeutics, and the development of novel approaches to enable personalized cancer medicine.